ImmuneOncia Therapeutics, Inc. (KOSDAQ:424870)

South Korea flag South Korea · Delayed Price · Currency is KRW
5,130.00
+20.00 (0.39%)
At close: Aug 13, 2025, 3:30 PM KST
-8.39%
Market Cap 379.14B
Revenue (ttm) 654.54M
Net Income (ttm) -5.69B
Shares Out 73.91M
EPS (ttm) -101.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 155,147
Average Volume 853,639
Open 5,190.00
Previous Close 5,110.00
Day's Range 5,060.00 - 5,210.00
52-Week Range 4,455.00 - 8,300.00
Beta n/a
RSI 39.99
Earnings Date n/a

About ImmuneOncia Therapeutics

ImmuneOncia Therapeutics, Inc., an immuno-oncology-centric biopharmaceutical company, develops immuno-oncology drugs for the treatment of cancer. It develops IMC-001, a human monoclonal antibody of the IgG1 type that targets PD-L1 an immunotherapy for cancer, which is in Phase II clinical trial for the treatment of NK/T cell lymphoma and solid cancer patients with high tumor mutation burden; and IMC-002, a human monoclonal antibody of the IgG4 type targeting human CD47, which is in Phase I a clinical trial for the treatment of solid cancers, su... [Read more]

Industry Pharmaceutical Preparations
Founded 2016
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 424870
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.